Abstract
Direct oral anticoagulants (DOACs) are now used to prevent venous thromboembolism (VTE) following total knee and hip replacements (TKR and THR). This meta-analysis was conducted to quantitatively pool the incremental net benefit (INB) of using DOACs for the prevention of VTE in a population undergoing TKR or THR surgeries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
